Preliminary efficacy and safety of total neoadjuvant therapy combined with PD-L1 blockade in pMMR/MSS locally advanced rectal cancer (ESTIMATE): A prospective, single-arm, phase II trial. This is an ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...
LOS ANGELES--(BUSINESS WIRE)--Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology, ...
Morning Overview on MSN
Study finds possible radiation-linked chromosome changes in NK defectors
South Korea’s national radiation research institute screened 80 North Korean defectors for signs of past radiation exposure ...
Co announces it has entered into a definitive acquisition agreement to purchase the fluorescent in situ hybridization business of Supreme Well Investments Limited and Molecular Diagnostics ...
Agilent says the acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth through customer-centric innovation and disciplined capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results